Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 Supply Disruption — RLC Labs Inc. (Moderate Risk
Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 Supply Disruption — RLC Labs Inc. (Moderate Risk is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95; Manufacturer: RLC La
| Drug name | Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 |
|---|---|
| Manufacturer | RLC Labs Inc. |
| Recall/Disruption reason | CGMP Deviations: manufactured under the same conditions as those found to be subpotent. |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-1604-2020 |
| Initiation date | 20200825 |
| Quantity affected | N/A |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →